Aosecon Reverse Takeover Oriental New Star Listed Case Analysis

China is a country with a large population and diverse needs in the field of health.The pharmaceutical market is huge and developing rapidly.At present,the number of domestic pharmaceutical enterprises is large,but the scale is small,the overall scientific research strength and new drug research and development ability is low,the main products are still in the development stage of imitation medicine,product quality problems frequently,fierce industrial competition and other problems are still very prominent,and there is a big gap compared with the developed countries in Europe and the United States.Therefore,in this environment,the government through the introduction of corresponding policies and measures to optimize the supervision and guidance of the pharmaceutical industry.Promote some powerful pharmaceutical enterprises to solve the problems facing the current pharmaceutical enterprises through mergers and acquisitions,listing and other ways,in order to achieve enterprise development goals,so as to achieve the healthy and green development of the medical and health industry.In this paper,through case analysis of orsay kang-pharmaceutical manufacturing segments of unicorns backdoor Beijing Oriental star listed as an example,case analysis,and analyzes the general situation of the enterprises on both sides,the listing process,motivation and risk,and financial indicators and non-financial analysis method is used to orsay,listed company’s performance is evaluated,Finally,the financial effect of the listed performance of Osakon is obtained.The research results show that the market performance,financial performance and non-financial performance of Oasecon are significantly improved after the backdoor listing.This paper takes the acquisition of Oasecon as an example to analyze the motivation of its acquisition and its impact on corporate performance.Orsay kang experience also suggests that reverse merger case,pharmaceutical manufacturing enterprises backdoor listings must consider comprehensively,backdoor listings must first consider their own strength,choose the right on the underlying shell company resources in trading decision science choose assets reorganization plan completes the control inspection,beware of insider information leakage and speculation.In addition,the integration management of mergers and acquisitions should start from research and development to improve the efficiency of asset management and utilization,attach importance to resource integration and strengthen risk management.